Teemu Palviainen

Teemu Palviainen

Auto-generated profile, based on publicly available information

Teemu Palviainen

Institute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MLMengzhen Liu
Mengzhen Liu
YJYu Jiang
Yu Jiang
RWRobbee Wedow
Robbee Wedow
YLYue Li
Yue Li
DBDavid M. Brazel
David M. Brazel
HPHunt All-In Psychiatry
Hunt All-In Psychiatry

29 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
GDGail Davies
Gail Davies
MLMax Lam
Max Lam
SHSarah E Harris
Sarah E Harris
JTJoey W Trampush
Joey W Trampush
MLMichelle Luciano
Michelle Luciano
IDIan Deary
Ian Deary
General cognitive function is a prominent and relatively stable human trait that is associated with many important life outcomes. We combine cognitive and genetic data from the CHARGE and COGENT consortia, and UK Biobank (totalN = 300,486; age 16–102) and find 148 genome-wide significant independent loci (P < 5 × 10−8) associated with general cognitive function. Within the novel genetic loci are variants associated with neurodegenerative and neurodevelopmental disorders, physical and psychiatric illnesses, and brain structure. Gene-based analyses find 709 genes associated with general cognitive function. Expression levels across the cortex are associated with general cognitive function. Using polygenic scores, up to 4.3% of variance in general cognitive function is predicted in independent samples. We detect significant genetic overlap between general cognitive function, reaction time, and many health variables including eyesight, hypertension, and longevity. In conclusion we identify novel genetic loci and pathways contributing to the heritability of general cognitive function.

26 November 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RWRaymond K. Walters
Raymond K. Walters
RPRenato Polimanti
Renato Polimanti
EJEmma Johnson
Emma Johnson
JMJeanette N. McClintick
Jeanette N. McClintick
MAMark J. Adams
Mark J. Adams
AAArpana Agrawal
Arpana Agrawal

9 May 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LHLaurence J. Howe
Laurence J. Howe
MNMichel G. Nivard
Michel G. Nivard
TMTim Morris
Tim Morris
AHAilin F. Hansen
Ailin F. Hansen
HRHumaira Rasheed
Humaira Rasheed
NDNeil M. Davies
Neil M. Davies
Estimates from genome-wide association studies (GWAS) of unrelated individuals capture effects of inherited variation (direct effects), demography (population stratification, assortative mating) and relatives (indirect genetic effects). Family-based GWAS designs can control for demographic and indirect genetic effects, but large-scale family datasets have been lacking. We combined data from 178,086 siblings from 19 cohorts to generate population (between-family) and within-sibship (within-family) GWAS estimates for 25 phenotypes. Within-sibship GWAS estimates were smaller than population estimates for height, educational attainment, age at first birth, number of children, cognitive ability, depressive symptoms and smoking. Some differences were observed in downstream SNP heritability, genetic correlations and Mendelian randomization analyses. For example, the within-sibship genetic correlation between educational attainment and body mass index attenuated towards zero. In contrast, analyses of most molecular phenotypes (for example, low-density lipoprotein-cholesterol) were generally consistent. We also found within-sibship evidence of polygenic adaptation on taller height. Here, we illustrate the importance of family-based GWAS data for phenotypes influenced by demographic and indirect genetic effects.

13 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HWHeming Wang
Heming Wang
JLJacqueline M. Lane
Jacqueline M. Lane
SJSamuel E. Jones
Samuel E. Jones
HDHassan S. Dashti
Hassan S. Dashti
HOHanna M. Ollila
Hanna M. Ollila
RSRicha Saxena
Richa Saxena
Excessive daytime sleepiness (EDS) affects 10–20% of the population and is associated with substantial functional deficits. Here, we identify 42 loci for self-reported daytime sleepiness in GWAS of 452,071 individuals from the UK Biobank, with enrichment for genes expressed in brain tissues and in neuronal transmission pathways. We confirm the aggregate effect of a genetic risk score of 42 SNPs on daytime sleepiness in independent Scandinavian cohorts and on other sleep disorders (restless legs syndrome, insomnia) and sleep traits (duration, chronotype, accelerometer-derived sleep efficiency and daytime naps or inactivity). However, individual daytime sleepiness signals vary in their associations with objective short vs long sleep, and with markers of sleep continuity. The 42 sleepiness variants primarily cluster into two predominant composite biological subtypes - sleep propensity and sleep fragmentation. Shared genetic links are also seen with obesity, coronary heart disease, psychiatric diseases, cognitive traits and reproductive ageing.

13 March 2023 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NSNick Shrine
Nick Shrine
AIAbril G. Izquierdo
Abril G. Izquierdo
JCJing Chen
Jing Chen
RPRichard Packer
Richard Packer
RHRobert J. Hall
Robert J. Hall
MTMartin D. Tobin
Martin D. Tobin
Lung-function impairment underlies chronic obstructive pulmonary disease (COPD) and predicts mortality. In the largest multi-ancestry genome-wide association meta-analysis of lung function to date, comprising 588,452 participants, we identified 1,020 independent association signals implicating 559 genes supported by ≥2 criteria from a systematic variant-to-gene mapping framework. These genes were enriched in 29 pathways. Individual variants showed heterogeneity across ancestries, age and smoking groups, and collectively as a genetic risk score showed strong association with COPD across ancestry groups. We undertook phenome-wide association studies for selected associated variants as well as trait and pathway-specific genetic risk scores to infer possible consequences of intervening in pathways underlying lung function. We highlight new putative causal variants, genes, proteins and pathways, including those targeted by existing drugs. These findings bring us closer to understanding the mechanisms underlying lung function and COPD, and should inform functional genomics experiments and potentially future COPD therapies.